Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 2 results

ea0004oc32 | Neuroendocrinology and diabetes | SFE2002

THE EFFECTS OF THIAZOLIDINEDIONE AND BIGUANIDE COMBINATION THERAPY ON SERUM LIPID CONCENTRATIONS AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

Buse J , Peters|#Harmel A , Kendall D , Boyle P , Marchetti A

Background: The anti-hyperglycemic effects of thiazolidinedione/biguanide combination therapy are well established. However, the impact of such therapy on other clinical risk factors for cardiovascular disease (CVD) has not been extensively reported.Objective: To evaluate the anti-hyperlipidemic effects of pioglitazone (PIO) and rosiglitazone (ROSI) used in combination with metformin (MET) in patients with type 2 diabetes, a multicenter, retrospective, r...
0 shares

ea0004dp28 | Diabetes, metabolism and cardiovascular | SFE2002

THE EFFECTS OF THIAZOLIDINEDIONE AND BIGUANIDE COMBINATION THERAPY ON SERUM LIPID CONCENTRATIONS AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

Buse J , Peters|#Harmel A , Kendall D , Boyle P , Marchetti A

Background: The anti-hyperglycemic effects of thiazolidinedione/biguanide combination therapy are well established. However, the impact of such therapy on other clinical risk factors for cardiovascular disease (CVD) has not been extensively reported.Objective: To evaluate the anti-hyperlipidemic effects of pioglitazone (PIO) and rosiglitazone (ROSI) used in combination with metformin (MET) in patients with type 2 diabetes, a multicenter, retrospective, r...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more